Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bibbin T Paul

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Breast Cancer Research : BCR|January 14, 2015
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancersZannel Blanchard, Bibbin T Paul, Barbara Craft, et al.
Breast Cancer Research : BCR|April 25, 2019
The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cellsDaniel Ryan, Bibbin T Paul, Jim Koziol, et al.
Cancer Research|January 9, 2020
The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated MacrophagesEman Sami, Bibbin T Paul, James A Koziol, et al.
Expert Review of Hematology|December 3, 2016
Mitochondria and Iron: current questionsBibbin T Paul, David H Manz, Frank M Torti, et al.
Annals of the New York Academy of Sciences|February 19, 2016
Iron and cancer: recent insightsDavid H Manz, Nicole L Blanchette, Bibbin T Paul, et al.
Scientific Reports|December 25, 2019
Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymesBibbin T Paul, Lia Tesfay, C R Winkler, et al.
Annual Review of Nutrition|August 22, 2018
Iron and CancerSuzy V Torti, David H Manz, Bibbin T Paul, et al.
Journal of Theoretical Biology|March 2, 2020
Systems biology of ferroptosis: A modeling approachAnna Konstorum, Lia Tesfay, Bibbin T Paul, et al.
Scientific Reports|November 19, 2022
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancerLia Tesfay, Bibbin T Paul, Poornima Hegde, et al.
Journal of Photochemistry and Photobiology. B, Biology|November 4, 2008
Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agentsBibbin T Paul, Mani S Babu, Thankayyan R Santhoshkumar, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Breast Cancer Research : BCR|January 14, 2015
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancersZannel Blanchard, Bibbin T Paul, Barbara Craft, et al.
Breast Cancer Research : BCR|April 25, 2019
The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cellsDaniel Ryan, Bibbin T Paul, Jim Koziol, et al.
Cancer Research|January 9, 2020
The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated MacrophagesEman Sami, Bibbin T Paul, James A Koziol, et al.
Expert Review of Hematology|December 3, 2016
Mitochondria and Iron: current questionsBibbin T Paul, David H Manz, Frank M Torti, et al.
Annals of the New York Academy of Sciences|February 19, 2016
Iron and cancer: recent insightsDavid H Manz, Nicole L Blanchette, Bibbin T Paul, et al.
Scientific Reports|December 25, 2019
Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymesBibbin T Paul, Lia Tesfay, C R Winkler, et al.
Annual Review of Nutrition|August 22, 2018
Iron and CancerSuzy V Torti, David H Manz, Bibbin T Paul, et al.
Journal of Theoretical Biology|March 2, 2020
Systems biology of ferroptosis: A modeling approachAnna Konstorum, Lia Tesfay, Bibbin T Paul, et al.
Scientific Reports|November 19, 2022
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancerLia Tesfay, Bibbin T Paul, Poornima Hegde, et al.
Journal of Photochemistry and Photobiology. B, Biology|November 4, 2008
Biophysical evaluation of two red-shifted hypocrellin B derivatives as novel PDT agentsBibbin T Paul, Mani S Babu, Thankayyan R Santhoshkumar, et al.
Pageof 2